Presenilin 1 deficiency suppresses autophagy in human neural stem cells through reducing γ-secretase-independent ERK/CREB signaling

Cell Death & Disease
Cheong-Meng ChongHuanxing Su

Abstract

Autophagy impairment is commonly implicated in the pathological characteristic of Alzheimer's disease (AD). Presenilin 1 (PS1) expression in human brain gradually decreases with age and its mutations account for the most common cases of early-onset familial Alzheimer's disease (FAD). The dominant autophagy phenotypes occur in PS1-knockout and PS1 mutant neurons; it is still unknown whether PS1 deficiency causes serious autophagy impairment in neural stem cells (NSCs). Herein, we generated the heterozygote and homozygote of PS1 knockout in human induced pluripotent stem cells (iPSCs) via CRISPR/Cas9-based gene editing and differentiated them into human NSCs. In these human PS1-deficient NSCs, reduced autophagosome formation and downregulated expression of autophagy-lysosome pathway (ALP)-related mRNAs, as well as proteins were observed. Mechanistically, ERK/CREB inhibition and GSK3β activation had key roles in reducing TFEB expression in PS1-knockout NSCs. Pharmacological inhibition of GSK3β upregulated the expression of TFEB and ALP-related proteins in PS1-knockout NSCs, whereas this effect could be blocked by CREB inhibition. These findings demonstrate that PS1 deficiency causes autophagy suppression in human NSCs via downregu...Continue Reading

References

Feb 27, 1996·Biochemical and Biophysical Research Communications·T SuzukiY Sakaki
Jun 2, 2000·Science·D L ClarkeJ Frisén
May 5, 2004·The Journal of Cell Biology·Christina A WilsonVirginia M-Y Lee
Aug 12, 2004·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Gopal Thinakaran, Angèle T Parent
Aug 28, 2004·Journal of Neuropathology and Experimental Neurology·Anne M CataldoRalph A Nixon
May 11, 2006·American Journal of Human Genetics·Robert SteinfeldJutta Gartner
Feb 23, 2007·The Journal of Biological Chemistry·Mario NizzariClaudio Russo
Oct 25, 2007·Cell·Dennis J Selkoe, Michael S Wolfe
Nov 17, 2007·Genes & Development·Noboru Mizushima
Nov 23, 2007·Journal of Cell Science·Ralph A Nixon
Jun 13, 2009·The Journal of Biological Chemistry·Jianrong WangTed Denmark
Feb 8, 2011·Neurobiology of Disease·Ralph A Nixon, Dun-Sheng Yang
Mar 19, 2011·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Kara M NeelyFrank M LaFerla
Dec 24, 2011·Molecular Neurodegeneration·Yangling Mu, Fred H Gage
Jun 23, 2012·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Xulun ZhangSangram S Sisodia
Jun 12, 2013·Cell Stem Cell·Florian T Merkle, Kevin Eggan
Nov 11, 2014·Nature·Sunmi SeokJongsook Kim Kemper
May 20, 2015·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Julien BrubanNikolaos K Robakis
Jul 24, 2015·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Bao-quan SongZhong-chao Han
Oct 27, 2015·Cellular Signalling·Stephen P Duggan, Justin V McCarthy
Mar 1, 2016·Cell Reports·Kavya ReddyRadek Dobrowolski
Aug 30, 2016·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·UNKNOWN Alzheimer's Association
Sep 13, 2016·Nature Cell Biology·Yang LiChonglin Yang
May 24, 2017·Proceedings of the National Academy of Sciences of the United States of America·Victor BustosPaul Greengard
May 24, 2017·Proceedings of the National Academy of Sciences of the United States of America·Victor BustosPaul Greengard

❮ Previous
Next ❯

Citations

Mar 3, 2019·Cells·Naoto Oikawa, Jochen Walter
Jun 30, 2019·Journal of Cellular Physiology·Huaiqing LuoJin Xu
Aug 29, 2019·Journal of Dental Research·X HongH Y Yang
Sep 11, 2019·CNS Neuroscience & Therapeutics·Huang KuangShu-Long Yang
Jul 15, 2020·International Journal of Molecular Sciences·Maria Victoria Niklison-ChirouGerry Melino
Aug 18, 2020·Journal of Alzheimer's Disease : JAD·Carol A Deaton, Gail V W Johnson
Feb 11, 2020·American Journal of Physiology. Renal Physiology·Lele LiuGang Xu
Aug 15, 2020·Molecular Psychiatry·Jose Henrique LedoPaul Greengard
Jul 17, 2020·Journal of the Endocrine Society·Tomomi KurashigeYuji Nagayama
May 14, 2020·International Journal of Molecular Sciences·Hyungsun ParkSeongju Lee
Nov 28, 2020·Stem Cell Reviews and Reports·Mina KolahdouzmohammadiSara Pahlavan
Jan 15, 2020·Current Neuropharmacology·Yuan ZhaoGuofeng Yang
Apr 4, 2021·International Journal of Molecular Sciences·Mehdi EshraghiSaeid Ghavami
Aug 21, 2021·Frontiers in Cell and Developmental Biology·Shanshan ChenDi Wang
Aug 31, 2021·The EMBO Journal·Daniel J KlionskyFederico Pietrocola
Nov 25, 2021·Journal of Proteome Research·Evan E HubbardRyan R Julian

❮ Previous
Next ❯

Methods Mentioned

BETA
reverse transcription PCR
nuclear translocation
confocal microscopy
electrophoresis

Software Mentioned

ImageJ
GraphPad Prism
Image Lab
GraphPad
Java

Related Concepts

Related Feeds

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.

Cell Fate Conversion By mRNA

mRNA-based technology is being studied as a potential technology that could be used to reprogram cell fate. This technique provides the potential to generate safe reprogrammed cells that can be used for clinical applications. Here is the latest research on cell fate conversion by mRNA.

Autophagy & Disease

Autophagy is an important cellular process for normal physiology and both elevated and decreased levels of autophagy are associated with disease. Here is the latest research.

Autophagosome

An autophagosome is the formation of double-membrane vesicles that involve numerous proteins and cytoplasmic components. These double-membrane vesicles are then terminated at the lysosome where they are degraded. Discover the latest research on autophagosomes here.

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

Alzheimer's Disease: Endosomes

Dysfunctional endosomal trafficking may be associated with Alzheimer’s disease (AD) pathology. Targeting the endosome may advance treatment options for AD. Here is the latest research on endosomes and AD.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Autophagy Networks

Autophagy is a lysosomal pathway that involves degradation of proteins and functions in normal growth and pathological conditions, through a series of complex networks. The catabolic process involves delivery of proteins and organelles to the lysosome. Here is the latest research on autophagy networks.

Autophagosome

An autophagosome is the formation of double-membrane vesicles that involve numerous proteins and cytoplasmic components. These double-membrane vesicles are then terminated at the lysosome where they are degraded. Discover the latest research on autophagosomes here.

Related Papers

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
Lili CaoShuzhen Wang
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
Lisa MosconiAlberto Pupi
Rinshō shinkeigaku = Clinical neurology
Takuya YagiNorihiro Suzuki
© 2022 Meta ULC. All rights reserved